Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | BLM | P54132 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | PPARG | P37231 | 1/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.60 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.60 |
| ▸ | FPR2 | P25090 | 4/20 | 0.55 |
| ▸ | TGM2 | P21980 | 1/20 | 0.54 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | AVPR2 | P30518 | 3/20 | 0.46 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.43 |
| ▸ | NPY4R | P50391 | 2/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18617 | 1.00 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL30207638 | 1.00 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL10325011 | 0.99 | MEN1 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL31337069 | 0.99 | MEN1 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL29593395 | 0.99 | MEN1 (0.61) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL3903552 | 0.99 | MEN1 (0.61) | MEN1BLMKMT2AUSP2POLB | |
| Perchlorate SCHEMBL31688153 | 0.95 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| Acetic Acid SCHEMBL29510237 | 0.95 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL3506817 | 0.95 | MEN1 (0.60) | MEN1BLMKMT2AUSP2POLB | |
| Piperazine SCHEMBL1317991 | 0.95 | MEN1 (0.55) | MEN1BLMKMT2AUSP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712948-A2 | GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME | Renagade Therapeutics Management Inc. (US) | 2026-03-25 | — | — | EP | claimed |
| CN-119455243-A | Pioglitazone hydrochloride microneedle drug delivery system for treating type II diabetes and preparation method thereof | 杭州医学院 | 2025-02-18 | — | — | CN | claimed |
| WO-2024238828-A2 | GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2024-11-21 | — | — | WO | claimed |
| EP-2694115-B1 | OPTICAL IMAGING PROBES | UNIV COURT UNIV OF EDINBURGH (GB) | 2024-10-23 | — | — | EP | claimed |
| EP-3661539-B1 | OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY | UNIV CALIFORNIA (US) | 2024-10-09 | — | — | EP | claimed |
| CN-118653008-A | HPV16 and HPV18 typing detection kit and application thereof | 广州朗坤生物科技有限公司 | 2024-09-17 | — | — | CN | claimed |
| EP-4243037-B1 | PEROVSKITE RADIOVOLTAIC-PHOTOVOLTAIC CELL | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2024-08-21 | — | — | EP | claimed |
| EP-4157838-B1 | THIAZOLOXIME AND OXAZOLOXIME DERIVATIVES AS REACTIVATORS OF ORGANOPHOSPHOROUS NERVE AGENT (OPNA)-INHIBITED HUMAN ACETYLCHOLINESTERASE FOR THE TREATMENT OF NERVOUS AND/OR RESPIRATORY FAILURE AFTER INTOXICATION WITH OPNA | CENTRE NAT RECH SCIENT (FR) | 2024-07-10 | — | — | EP | claimed |
| EP-3507603-B1 | COMPOSITIONS AND METHODS FOR ENHANCED FLUORESCENCE | LIFE TECHNOLOGIES CORP (US) | 2024-03-06 | — | — | EP | claimed |
| CN-116930138-A | Preparation method of hyaluronic acid-gold nanostructure for detecting active oxide | 南昌大学第二附属医院 | 2023-10-24 | — | — | CN | claimed |
| US-11643560-B2 | Ink, ink stored container, inkjet printing method, and inkjet printing apparatus | RICOH COMPANY, LTD. (JP) | 2023-05-09 | — | — | US | claimed |
| CN-111735803-B | Construction and application of nano microporous material fluorescence resonance energy transfer system | 莆田学院 | 2023-01-31 | — | — | CN | claimed |
| US-20260142201-A1 | ADHESIVE COMPOSITION FOR FUEL CELL SEALING MEMBERS, MEMBER FOR FUEL CELLS, AND METHOD FOR PRODUCING MEMBER FOR FUEL CELLS | SUMITOMO RIKO COMPANY LIMITED (JP) | 2026-05-21 | — | — | US | disclosed |
| US-20260137614-A1 | ANHYDROUS COMPOSITION FOR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2026-05-21 | — | — | US | disclosed |
| CN-122028903-A | Composition for caring for and/or making up keratin materials | 莱雅公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-122028904-A | Composition for caring for and/or making up keratin materials | 莱雅公司 | 2026-05-12 | — | — | CN | disclosed |
| US-11247226-B2 | Process for forming a multilayered shaped film product | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-02-15 | — | — | US | disclosed |
| CN-109824683-B | Rhodamine B Hg based on 2-thiopheneacetyl chloride2+Preparation and application of fluorescent sensor | 南京林业大学 | 2022-02-11 | — | — | CN | disclosed |
| US-11229584-B2 | Pigment dispersion liquid for cosmetics, and aqueous liquid cosmetic using same | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2022-01-25 | — | — | US | disclosed |
| US-11229710-B2 | Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors | UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11229710-B2 | Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors | PHLPP1, PHLPP2, GHITM | CHRM1 4876/4885MEN1 725/4885BLM 2846/4885 |
| US-20260137614-A1 | ANHYDROUS COMPOSITION FOR MAKING UP KERATIN MATERIALS | KRT18, F12, DEGS1 | CHRM1 2244/4885MEN1 1638/4885BLM 3657/4885 |
| US-20260142201-A1 | ADHESIVE COMPOSITION FOR FUEL CELL SEALING MEMBERS, MEMBER FOR FUEL CELLS, AND METHOD FOR PRODUCING MEMBER FOR FUEL CELLS | EPCAM, CDH1, ILK | CHRM1 2612/4885MEN1 1052/4885BLM 1270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.